GALT
Galectin Therapeutics Inc
4.00$
+1.9%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -30.0% | +0.0% | -85.7% | +0.0% | +3,400.0% | +2.9% | +13.9% | -22.0% | +3.1% | +12.1% | +43.2% | |
| – | -16.5% | -27.1% | -55.6% | +303.7% | -62.1% | +6.9% | +15.4% | +38.1% | -21.1% | +8.2% | -32.2% | |
| – | -23.9% | -27.1% | -53.8% | +318.2% | -63.1% | +6.6% | +28.7% | +12.1% | – | – | – | |
| – | – | – | -131.6% | – | – | +47.0% | +298.2% | +32.4% | -5.8% | -51.2% | -73.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -21.4% | +66.3% | -25.7% | -56.9% | -65.2% | +24.8% | -43.3% | +23.7% | -24.2% | +51.6% | |
| – | -56.5% | -56.8% | -88.3% | +2,109.6% | +228.2% | -99.5% | -11,506.8% | – | -25.4% | +25.9% | -21.1% | |
| – | – | – | – | – | +0.0% | +0.0% | +0.0% | -66.7% | +200.0% | +0.0% | -30.0% | |
| – | -56.5% | -56.8% | -39.5% | +329.2% | +225.6% | -99.5% | +13,897.7% | -72.8% | +300.3% | -22.0% | -15.2% | |
| – | -117.6% | – | – | – | +654.4% | -151.8% | – | -268.4% | – | -249.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.